RankAlpha logo
Back to Rankings

NAMS

NewAmsterdamB
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
View Chart
+
Peers tracked
8
U.S. public peers
Grade Position
In line
vs peer average
NAMS vs peer average
60/100
NAMS vs. peer average (B vs. C)
Grade spread
A 2 · B 1 · C 4 · F 1
Graded peers loaded
Coverage
8 graded
100% of tracked

Peer overview

KNSA is the first available peer comparator.

Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $3.61B

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerKNSAKiniksa International
NAMS
NewAmsterdam
KNSA
Kiniksa International
Grade
B
C
Momentum
77
77
Value
41
60
Sentiment
-
26
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Constructive
Mixed
Open Side-by-Side ComparisonCompare all

Grade position vs KNSA

NAMS / KNSA
Grade Position
In line
NAMS vs. peer average (B vs. C)
60/100
Momentum
77
KNSA
Value
41
KNSA
Sentiment
-
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs NAMS
1
KNSA
Kiniksa Pharmaceuticals International plc Class A Common
C
60/100
+1
2
VCYT
Veracyte Inc Common
B
80/100
Even
3
CPRX
Catalyst Pharmaceuticals Inc Common
A
100/100
-1
4
ACAD
ACADIA Pharmaceuticals Inc Common
C
60/100
+1
5
TXG
10x Genomics Inc Class A Common
C
60/100
+1
KNSA is the first peer returned for this comparison set.